Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02835339 · ClinicalTrials.gov registry record · Phase 4
Magnesium Sulfate in Obese Preeclamptics
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
NCT02835339: Completed Phase 4 study, sponsored by Oregon Health and Science University.
NCT02835339 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 66 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02835339, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to learn how medications participant will receive in the course of their delivery are metabolized (broken down by the body). The investigators hope to learn more about the way drugs are metabolized by pregnant women, and how those drugs are distributed in the blood and body compartments and cleared in the urine, and how maternal body weight affects the metabolism. With this information the investigators will be able to develop a treatment regimen considering factors in the body that affect magnesium levels so that the investigators can improve treatment of pregnant women. The goal of the study is to understand how different dosing of magnesium sulfate affects blood levels of the magnesium in larger women.
Primary Outcome
magnesium level in mg/dL
Interventions
- DRUG Magnesium sulfate 4g loading dose, 1g/hr infusion
- DRUG Magnesium sulfate 6g loading dose, 2g/hr infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2016-07-12 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 4 |
What the finished NCT02835339 record still lists
NCT02835339 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Magnesium sulfate 4g loading dose, 1g/hr infusion is the first listed.
NCT02835339 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02835339 about?
NCT02835339 is a clinical study titled "Magnesium Sulfate in Obese Preeclamptics". The purpose of this study is to learn how medications participant will receive in the course of their delivery are metabolized (broken down by the body). The investigators hope to learn more about the way drugs are metabolized by pregnant women, and how those drugs are distributed in the blood and b...
What is the current status of trial NCT02835339?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 2016-07-12. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02835339?
The interventions under investigation include: Magnesium sulfate 4g loading dose, 1g/hr infusion (DRUG), Magnesium sulfate 6g loading dose, 2g/hr infusion (DRUG).
Who is sponsoring clinical trial NCT02835339?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02835339's enrollment target sits among peer trials
66 1083rd of 2000 higher than 910 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI